Ministry of Health and Prevention issued a warning against three pharmaceutical products, one of which is used for the treatment of pulmonary fibrosis.
The ministry also suspended a drug prescribed for the treatment of diabetes and warned of a dietary supplement due to its risk of blood pressure.